| Members |
targetComponentId |
| Disrupted laceration wound site |
Disrupted wound |
| Dissecting aneurysm of coronary artery |
Dissection of coronary artery (disorder) |
| Disseminated chorioretinitis and retinochoroiditis NOS |
Disseminated chorioretinitis |
| Disseminated paracoccidioidomycosis |
Disseminated paracoccidioidomycosis (disorder) |
| Dist fasciocutaneous flap NOS |
Distant fasciocutaneous flap |
| Distal interphalangeal joint structure of great toe |
Interphalangeal joint structure of great toe |
| Distal monosomy 20q syndrome |
20q13.33 microdeletion syndrome (disorder) |
| Distal myopathy with early respiratory muscle involvement |
Hereditary myopathy with early respiratory failure |
| Distant cutaneous pedicle skin flap NOS |
Reconstruction using distant pedicle skin flap |
| Distant fasciocutaneous flap to head or neck NEC |
Distant fasciocutaneous flap |
| Distant free flap reconstruction - action |
Distant flap reconstruction - action (qualifier value) |
| Distant myocutaneous flap NOS |
Distant myocutaneous flap |
| Distant myocutaneous flap to head or neck NEC |
Distant myocutaneous flap |
| Distant pedicle flap reconstruction - action |
Distant flap reconstruction - action (qualifier value) |
| Distant skin flap to head or neck NEC |
Reconstruction with distant flap |
| Distant subcutaneous pedicle flap, axial pattern NEC |
Reconstruction using distant subcutaneous pedicle axial pattern flap (procedure) |
| Distant subcutaneous pedicle flap, fasciocutaneous NEC |
Distant fasciocutaneous flap |
| Distant subcutaneous pedicle flap, myocutaneous NEC |
Distant myocutaneous flap |
| Distant subcutaneous pedicle flap, random pattern NEC |
Reconstruction using distant subcutaneous pedicle random pattern flap (procedure) |
| Disto-occlusion |
Disto-occlusion of teeth |
| Disturbance in form of thinking |
Disorder of form of thought |
| Dithranol cream allergy |
Allergy to dithranol (finding) |
| Dithranol ointment allergy |
Allergy to dithranol (finding) |
| Dithranol paste allergy |
Allergy to dithranol (finding) |
| Divalproex sodium 125mg tablet delayed release |
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Divalproex sodium 250mg tablet delayed release |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Divalproex sodium 500mg m/r tablet |
Valproic acid only product in oral dose form |
| Divalproex sodium 500mg prolonged-release oral tablet |
Valproic acid only product in oral dose form |
| Diversional therapy |
Diversional therapy |
| embranchement : Tenericutes |
Phylum Tenericutes (organism) |
| section de l'aponévrose palmaire pour traiter la maladie de Dupuytren |
Division of palmar aponeurosis for correction of Dupuytren contracture (procedure) |
| dobutamine 12,5 mg/mL, flacon de 20 mL d'un concentré pour perfusion |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| dobutamine 50 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Dobutamine (as dobutamine hydrochloride) 50 mg/mL solution for injection |
| Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Does not, dependent |
Does not |
| Dog allergy vaccine |
Dog allergy vaccine (product) |
| Doll's eye sign |
Doll's head reflex |
| Dolphin distemper virus |
Cetacean morbillivirus (organism) |
| Domain Archaea |
Domain Archaea |
| Domestic animal species, non-primate |
Class Mammalia (organism) |
| Domestic animals |
Class Mammalia (organism) |
| Domestic partner of subject |
Domestic partner (person) |
| Donepezil 10mg orally disintegrating tablet |
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| Donepezil 1mg/mL oral solution |
Donepezil hydrochloride 1 mg/mL oral solution |
| Donepezil 5mg orally disintegrating tablet |
Donepezil hydrochloride 5 mg orodispersible tablet |
| chlorhydrate de dopamine 160 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| chlorhydrate de dopamine 40 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Dopamine hydrochloride 40 mg/mL solution for injection |
| chlorhydrate de dopéxamine 10 mg/mL, ampoule de 5 mL de concentré pour perfusion |
Product containing precisely dopexamine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Dornase alfa 2500units(2.5mg) nebulizer solution |
Dornase alfa 1 mg/mL solution for nebuliser |
| Dorsal finger flap |
Flap (substance) |
| Dorsal metatarsal fasciocutaneous flap |
Dorsal metatarsal artery fasciocutaneous flap |
| Dorsal thumb flap |
Flap (substance) |
| Dorsal tongue flap |
Flap (substance) |
| Dorsalis pedis flap |
Dorsalis pedis artery flap |
| Dorsolateral sulcus |
Medulla oblongata dorsal lateral sulcus |
| forme pharmaceutique selon la voie d'administration |
Pharmaceutical dose form (dose form) |
| Dothiepin hydrochloride 25mg/5mL conventional release oral elixir |
Dosulepin 5 mg/mL oral solution |
| Dothiepin hydrochloride 25mg/5mL s/f elixir |
Dosulepin 5 mg/mL oral solution |
| Dothiepin hydrochloride 75mg/5mL conventional release oral elixir |
Dosulepin 15 mg/mL oral solution |
| Dothiepin hydrochloride 75mg/5mL s/f elixir |
Dosulepin 15 mg/mL oral solution |
| Double - DT - vaccination |
Preschool administration of diphtheria and tetanus vaccine |
| Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
| Double pedicle flap graft |
Reconstruction using bipedicled flap |
| Down's incontinence apparatus |
Incontinence appliance (physical object) |
| Doxazosin mesylate 8mg tablet |
Doxazosin (as doxazosin mesilate) 8 mg oral tablet |
| Doxepin hydrochloride 10mg/mL oral solution |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Doxepin metabolite |
Product containing doxepin (medicinal product) |
| Doxorubicin hydrochloride 10mg injection solution vial |
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
| Doxorubicin hydrochloride 20mg injection solution vial |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Doxorubicin liposomal 20mg/10ml injection |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Doxycycline 100mg dispersible tablet |
Doxycycline 100 mg orodispersible tablet |
| Doxycycline 40mg m/r capsule |
Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Doxycycline 75mg orally disintegrating tablet |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
| Doxycycline calcium 50mg/5mL syrup |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Doxycycline hyclate 10% subgingival delivery system |
Product containing only doxycycline in oromucosal dose form (medicinal product form) |
| Doxycycline hyclate 200mg injection (pdr for recon) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
| Doxycycline hyclate 200mg powder for injection solution vial |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
| Doxycycline monohydrate 25mg/5mL suspension |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
| Drain insertion - action |
Insertion - action (qualifier value) |
| Drainage of cyst NEC |
Drainage procedure |
| Drainage of organ NOC |
Drainage procedure |
| Drainage of organ NOC NOS |
Drainage procedure |
| Drechslera longirostrata |
Exserohilum longirostratum |
| Dressing - action |
Application - action |
| Dried factor IX fraction heated 600iu powder and solvent for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
| Dried factor IX fraction heated 600iu powder for conventional release solution for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
| Drilling of organ NOC |
Drilling |
| Drimaren brilliant yellow |
Textile colours and finishes patch test substance |
| Drop attacks in middle-aged woman |
Drop attack |
| Drostanolone propionate allergy |
Allergy to drostanolone (finding) |
| Drotrecogin alfa (activated) 5mg powder for infusion solution vial |
Drotrecogin alfa 5 mg powder for solution for injection vial |
| Drotrecogin alfa 20mg powder for infusion solution vial |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Drug |
Pharmaceutical / biologic product (product) |
| Drug aerosol, 0,01% |
Drug aerosol |
| Drug aerosol, 0,04% |
Drug aerosol |
| Drug aerosol, 0,5% |
Drug aerosol |
| Drug cream, 0,01% |
Cream |
| Drug cream, 0,02% |
Cream |
| Drug cream, 0,025% |
Cream |
| Drug cream, 0,05% |
Cream |
| Drug cream, 0,1% |
Cream |
FHIR